Literature DB >> 17551338

Cranio-osteoarthropathy in sibs.

Tabib Dabir1, A M Sills, Christine M Hall, Chris Bennett, Louise C Wilson, Raoul C M Hennekam.   

Abstract

Primary hypertrophic osteoarthropathy is a condition characterized by clubbing, arthropathy and periostosis of long tubular bones. Three variants of primary hypertrophic osteoarthropathy are distinguished: pachydermoperiostosis, which shows as additional symptom pachydermia; cranio-osteoarthropathy, which has a decreased neurocranium ossification as additional feature; and a secondary form. Primary hypertrophic osteoarthropathy is also genetically heterogeneous, with evidence for both autosomal dominant and autosomal recessive inheritance. We describe two sibs with cranio-osteoarthropathy and briefly review previously reported cases. The present cases demonstrate the phenotypic variability of the condition. The consanguinity in the present family and analysis of previously described cases support autosomal recessive inheritance for cranio-osteoarthropathy.

Entities:  

Mesh:

Year:  2007        PMID: 17551338     DOI: 10.1097/MCD.0b013e32801470d8

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  3 in total

1.  HPGD mutations cause cranioosteoarthropathy but not autosomal dominant digital clubbing.

Authors:  Wenke Seifert; Julia Beninde; Katrin Hoffmann; Tom H Lindner; Christian Bassir; Fuat Aksu; Christoph Hübner; Nienke E Verbeek; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2009-07-01       Impact factor: 4.246

2.  Primary hypertrophic osteoarthropathy caused by homozygous deletion in HPGD gene in a family: changing clinical and radiological findings with long-term follow-up.

Authors:  Beyhan Tüysüz; Saliha Yılmaz; Özgür Kasapçopur; Tuğba Erener-Ercan; Emre Ceyhun; Kaya Bilguvar; Murat Günel
Journal:  Rheumatol Int       Date:  2014-05-12       Impact factor: 2.631

Review 3.  Cranio-osteoarthropathy: a rare variant of hypertrophic osteoarthropathy.

Authors:  X Chen; C C Zou; G P Dong; L Liang; Z Y Zhao
Journal:  Ir J Med Sci       Date:  2009-05-09       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.